CAS: 1346452-25-2
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Enfortumab vedotin-ejfv REF: TM-T78065CAS: 1346452-25-2 | - - - | 790.00 €~6,230.00 € | Fri 08 Nov 24 | |
Enfortumab REF: 3D-CLA1341CAS: 1346452-25-2 | - - - | 1,102.00 €~6,260.00 € | Fri 13 Dec 24 |
Enfortumab vedotin-ejfv
CAS:1346452-25-2
Enfortumab vedotin-ejfv is an antibody-drug conjugate targeting Nectin-4, employed in the treatment of urothelial carcinoma …
Color and Shape:
Solid
Ref: TM-T78065
1mg | 790.00 € | ||
5mg | 2,297.00 € | ||
10mg | 3,110.00 € | ||
25mg | 4,613.00 € | ||
50mg | 6,230.00 € |
Estimated delivery in United States, on Friday 8 Nov 2024
Ref: 3D-CLA1341
1mg | 1,102.00 € | ||
5mg | 2,232.00 € | ||
10mg | 3,327.00 € | ||
25mg | 4,203.00 € | ||
50mg | 6,260.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024